Elevated core-fucosylated IgG is a new marker for hepatitis B virus-related hepatocellular carcinoma
Immunoglubulin G (IgG) and its abnormal glycosylations are associated with carcinogenesis. The present study investigates the relationship between cancer-derived IgG and clinicopathological characteristics in hepatocellular carcinoma (HCC) and assesses the value of serum N-glycosylated IgG in diagno...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
07 Jul 2015
|
| In: |
OncoImmunology
Year: 2015, Jahrgang: 4, Heft: 12 |
| ISSN: | 2162-402X |
| DOI: | 10.1080/2162402X.2015.1011503 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1080/2162402X.2015.1011503
|
| Verfasserangaben: | Chang-Hong Yi, Hong-Lei Weng, Fei-Guo Zhou, Meng Fang, Jun Ji, Cheng Cheng, Hao Wang, Roman Liebe, Steven Dooley, Chun-Fang Gao |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1562940716 | ||
| 003 | DE-627 | ||
| 005 | 20220813220413.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 170831s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/2162402X.2015.1011503 |2 doi | |
| 035 | |a (DE-627)1562940716 | ||
| 035 | |a (DE-576)492940711 | ||
| 035 | |a (DE-599)BSZ492940711 | ||
| 035 | |a (OCoLC)1340978890 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Yi, Chang-Hong |e VerfasserIn |0 (DE-588)1139134965 |0 (DE-627)897306031 |0 (DE-576)492940568 |4 aut | |
| 245 | 1 | 0 | |a Elevated core-fucosylated IgG is a new marker for hepatitis B virus-related hepatocellular carcinoma |c Chang-Hong Yi, Hong-Lei Weng, Fei-Guo Zhou, Meng Fang, Jun Ji, Cheng Cheng, Hao Wang, Roman Liebe, Steven Dooley, Chun-Fang Gao |
| 264 | 1 | |c 07 Jul 2015 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 31.08.2017 | ||
| 520 | |a Immunoglubulin G (IgG) and its abnormal glycosylations are associated with carcinogenesis. The present study investigates the relationship between cancer-derived IgG and clinicopathological characteristics in hepatocellular carcinoma (HCC) and assesses the value of serum N-glycosylated IgG in diagnosing and monitoring hepatitis B virus (HBV)-related HCC. Tissue microarray analysis of 90 HCC tissues showed that HCC patients with IgG immunopositivity had higher levels of core-fucosylated α fetoprotein (AFP-L3), larger tumors, and a higher incidence of portal vein tumor thrombus. HCC-derived IgG stimulated the growth of liver cancer cells in vitro. HCC patients presented a significantly increased fraction of Lens culinaris agglutinin binding IgG (core-fucosylated IgG, IgG-L3) among total serum IgG. The clinical diagnostic performance of serum IgG-L3% was evaluated in 3 case-control studies (1 training set and 2 validation cohorts), including 293 patients with HCC, 131 with liver cirrhosis, 132 HBV carriers, and 151 healthy controls. IgG-L3% had better general diagnostic performance than AFP in the training set and validation cohort 1 (accuracy: 81.33-85.11% versus 63.33-78.61%). In validation cohort 2, where we aimed to assess the efficiency of IgG-L3% in patients with AFP-negative HCC, the diagnostic accuracy of IgG-L3% was 72.54-73.60%. Finally, a longitudinal evaluation based on 31 HCC patients demonstrated that IgG-L3% decreased in 24 patients after curative surgery. The remaining 7 patients showed elevated IgG-L3% and post-operative recurrence. HCC patients with higher IgG-L3% had poor survival during a 3-year follow up. We conclude that HCC-derived IgG is correlated with progressive behavior of HCC. Therefore, elevated core-fucosylated IgG is a new diagnostic and prognostic marker in HBV-related HCC. | ||
| 650 | 4 | |a diagnosis | |
| 650 | 4 | |a hepatocellular carcinoma (HCC) | |
| 650 | 4 | |a IgG | |
| 650 | 4 | |a Lens culinaris agglutinin (LCA) | |
| 650 | 4 | |a non-invasive biomarker | |
| 650 | 4 | |a tissue array | |
| 700 | 1 | |a Weng, Honglei |d 1969- |e VerfasserIn |0 (DE-588)1033024074 |0 (DE-627)740785524 |0 (DE-576)38050572X |4 aut | |
| 700 | 1 | |a Liebe, Roman |e VerfasserIn |0 (DE-588)1056006226 |0 (DE-627)793131324 |0 (DE-576)412012138 |4 aut | |
| 700 | 1 | |a Dooley, Steven |d 1960- |e VerfasserIn |0 (DE-588)1028589190 |0 (DE-627)73128951X |0 (DE-576)376074116 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t OncoImmunology |d Abingdon : Taylor & Franics, 2012 |g 4(2015,12) Artikel-Nummer e1011503, 12 Seiten |h Online-Ressource |w (DE-627)683365428 |w (DE-600)2645309-5 |w (DE-576)356728366 |x 2162-402X |7 nnas |a Elevated core-fucosylated IgG is a new marker for hepatitis B virus-related hepatocellular carcinoma |
| 773 | 1 | 8 | |g volume:4 |g year:2015 |g number:12 |g extent:12 |a Elevated core-fucosylated IgG is a new marker for hepatitis B virus-related hepatocellular carcinoma |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/2162402X.2015.1011503 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/2162402X.2015.1011503 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20170831 | ||
| 993 | |a Article | ||
| 994 | |a 2015 | ||
| 998 | |g 1028589190 |a Dooley, Steven |m 1028589190:Dooley, Steven |d 60000 |d 61100 |e 60000PD1028589190 |e 61100PD1028589190 |k 0/60000/ |k 1/60000/61100/ |p 9 | ||
| 998 | |g 1056006226 |a Liebe, Roman |m 1056006226:Liebe, Roman |d 60000 |d 61100 |e 60000PL1056006226 |e 61100PL1056006226 |k 0/60000/ |k 1/60000/61100/ |p 8 | ||
| 998 | |g 1033024074 |a Weng, Honglei |m 1033024074:Weng, Honglei |d 60000 |d 61100 |e 60000PW1033024074 |e 61100PW1033024074 |k 0/60000/ |k 1/60000/61100/ |p 2 | ||
| 999 | |a KXP-PPN1562940716 |e 297893798X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"person":[{"role":"aut","display":"Yi, Chang-Hong","given":"Chang-Hong","family":"Yi"},{"display":"Weng, Honglei","role":"aut","family":"Weng","given":"Honglei"},{"given":"Roman","family":"Liebe","role":"aut","display":"Liebe, Roman"},{"family":"Dooley","given":"Steven","display":"Dooley, Steven","role":"aut"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"eki":["1562940716"],"doi":["10.1080/2162402X.2015.1011503"]},"physDesc":[{"extent":"12 S."}],"relHost":[{"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"OncoImmunology","title_sort":"OncoImmunology"}],"disp":"Elevated core-fucosylated IgG is a new marker for hepatitis B virus-related hepatocellular carcinomaOncoImmunology","note":["Gesehen am 13.12.2022"],"id":{"zdb":["2645309-5"],"issn":["2162-402X"],"eki":["683365428"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"part":{"text":"4(2015,12) Artikel-Nummer e1011503, 12 Seiten","issue":"12","extent":"12","year":"2015","volume":"4"},"pubHistory":["1.2012 -"],"titleAlt":[{"title":"Onco Immunology"}],"recId":"683365428","origin":[{"dateIssuedKey":"2012","publisherPlace":"Abingdon ; Austin, Tex.","dateIssuedDisp":"2012-","publisher":"Taylor & Franics ; Landes Bioscience"}]}],"title":[{"title_sort":"Elevated core-fucosylated IgG is a new marker for hepatitis B virus-related hepatocellular carcinoma","title":"Elevated core-fucosylated IgG is a new marker for hepatitis B virus-related hepatocellular carcinoma"}],"recId":"1562940716","name":{"displayForm":["Chang-Hong Yi, Hong-Lei Weng, Fei-Guo Zhou, Meng Fang, Jun Ji, Cheng Cheng, Hao Wang, Roman Liebe, Steven Dooley, Chun-Fang Gao"]},"note":["Gesehen am 31.08.2017"],"origin":[{"dateIssuedDisp":"07 Jul 2015","dateIssuedKey":"2015"}]} | ||
| SRT | |a YICHANGHONELEVATEDCO0720 | ||